Dual-Tracer 18 F-FDG and 68 Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy.

Abstract excerpt

PURPOSE: This study evaluated interlesion heterogeneity in prostate cancer using dual-tracer imaging (PSMA and FDG) and explored its predictive value for novel hormone therapy (NHT). PATIENTS AND METHODS: A total of 205 prostate cancer patients (23 biochemical recurrences, 68 metastatic castration-sensitive prostate cancers, 114 metastatic castration-resistant prostate cancers [mCRPC]) who underwent dual 18 F-FDG...

Topics

Join the communities discussing this publication.

• Aged, 80 and over
• Edetic Acid
• Fluorodeoxyglucose F18
• Neoplasm Metastasis
• Oligopeptides